Investigational melanoma vaccine receives breakthrough designation from U.S. FDA
Data from a Phase 2b study indicates that an investigational personalized mRNA cancer vaccine known as mRNA-4157/V940, in combination...
Investigational melanoma vaccine receives breakthrough designation from U.S. FDA
Methotrexate use associated with increased risk of some skin cancers
Fewer cases of melanoma seen in people taking vitamin D
Fractional laser Tx may prevent keratinocyte carcinoma
Abnormal expression of Lepr leptin receptor may drive SSC malignancy
Highest risk of multiple primary melanomas from indoor tanning
Nivolumab shows promise in advanced cutaneous squamous cell carcinoma
Models predict low mortality in certain patients with stage 1 melanoma